The Revue Francaise d'Allergologie, an esteemed publication in the field of Immunology and Allergy, is published by ELSEVIER MASSON, CORP OFF in France. This journal plays a pivotal role in disseminating significant findings and advancements in allergy research and immunotherapy, reflecting the latest trends and challenges in these rapidly evolving areas. As part of its commitment to scholarly rigor, the journal encompasses a wide range of topics pertinent to allergology, aiming to bridge the gap between clinical practice and academic research. Although currently not listed as open access, it provides critical insights essential for researchers, professionals, and students alike, ensuring the advancement of knowledge and therapeutic strategies in allergy and immunology. With its impact factor and positioning in the Q4 category, it serves as a valuable resource, aiding in the education and development of future leaders in the field. The Revue Francaise d'Allergologie continues to be a vital platform for the exchange of innovative ideas and findings from 2009 to the present.

Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.

Frontiers in Allergy is a pioneering open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the frontiers of research in the fields of Immunology and Infectious Diseases. Launched in 2020 and based in Lausanne, Switzerland, this journal provides a dynamic platform for researchers, professionals, and students to share innovative findings and insights related to allergic disorders and their broader immunological implications. With a respectable Q2 ranking in both Immunology and Allergy and Infectious Diseases categories, as well as being indexed in Scopus, this journal is emerging as a significant resource for the scientific community. The open-access model ensures wide dissemination of valuable knowledge, facilitating collaboration and breakthroughs in treatments and understanding of allergies and related conditions. Frontiers in Allergy invites contributions that drive forward the understanding of immune responses, allergy prevention, and management, solidifying its role as a crucial player in the sustainability and growth of health sciences.

The International Forum of Allergy & Rhinology, published by Wiley, is a leading journal dedicated to advancing the field of allergy, rhinology, and related health issues. With an ISSN of 2042-6976 and an E-ISSN of 2042-6984, this esteemed journal showcases high-quality research and innovative findings by publishing original articles, reviews, and clinical case studies. As of 2023, it holds impressive rankings within the Scopus metrics, placing it in the top 2% for Medicine in Otorhinolaryngology and in the top 16% for Immunology and Allergy, highlighting its influence and credibility in these specialized fields. Operating without an open access model, the journal aims to offer comprehensive insights into the diagnosis and treatment of allergic conditions and their impact on rhinology, fostering a deeper understanding among researchers and practitioners. Located in Hoboken, NJ, the journal has been at the forefront of scientific exploration since its inception in 2011, continuing to play a pivotal role in informing the academic community and influencing clinical practice up to 2024 and beyond.

Bangladesh Journal of Otorhinolaryngology is a prominent peer-reviewed journal dedicated to the field of otorhinolaryngology, providing a platform for the dissemination of innovative research and clinical findings related to ear, nose, and throat (ENT) disorders. Published by the SOC OTORHINOLARYNGOLOGISTS & HEAD NECK SURGEONS BANGLADESH, the journal aims to enhance medical knowledge, improve clinical practices, and promote evidence-based treatments among healthcare professionals. As an academic resource, it serves not only local but also international audiences, facilitating a deeper understanding of the challenges and advancements in ENT healthcare. Although published in Bangladesh, the journal's rigorous peer-review process and commitment to high academic standards position it as a significant contributor to global ENT research discourse. While currently not an open-access journal, it encourages subscription and institutional access, helping researchers and practitioners stay abreast of cutting-edge developments in the field.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

Therapeutic Advances in Allergy and Rhinology, published by SAGE Publications Inc, is an esteemed journal that focuses on advancing the fields of allergy and rhinology through innovative and impactful research. As an Open Access journal, it provides a platform for researchers, clinicians, and students to share significant findings and therapeutic developments aimed at improving patient outcomes related to allergic conditions and nasal disorders. The journal aims to publish high-quality peer-reviewed articles, reviews, and case studies that contribute to a deeper understanding of the pathophysiology and management of allergies and rhinological conditions. By fostering collaborative dialogue across various disciplines, Therapeutic Advances in Allergy and Rhinology plays a crucial role in enhancing clinical practice and guiding future research in this vital area of health. With an ISSN of 2753-4030, the journal continues to establish itself as a key resource for anyone involved in allergy and rhinology research and practice.

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal resource in the fields of pediatric otorhinolaryngology, pediatrics, and related medical disciplines. With a historical publication record spanning from 1979 to 2024, this journal is dedicated to advancing research and clinical practice in the diagnosis and treatment of ear, nose, and throat disorders in children. As evidenced by its 2023 rankings, the journal maintains a commendable position within the Q2 category of its field, reflecting its impact and the quality of research it disseminates, ranking #43 out of 123 in Otorhinolaryngology and #131 out of 330 in Pediatrics. Researchers, clinicians, and students alike can benefit from a wealth of studies and reviews designed to inform and enhance pediatric care. Although the journal does not currently offer open access, it remains an indispensable tool for those seeking to stay at the forefront of pediatric health and otolaryngological innovations.

Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.